Solesence Appoints Yoolie Park as VP of Brand Partnerships
Written by Emily J. Thompson, Senior Investment Analyst
Solesence has appointed Yoolie Park as Vice President of Brand Partnerships. In this role, Park will lead strategic relationships with emerging and established beauty brands, expanding Solesence's ability to deliver fully integrated, turnkey solutions that accelerate speed to market while enabling brands to deploy more working capital toward marketing and growth initiatives. Park joins Solesence from Paklab, where she held the position of Executive Vice President and was responsible for identifying new business opportunities, overseeing and maintaining brand relationships, and leading packaging and product development initiatives.
Trade with 70% Backtested Accuracy
Stop guessing
"Should I Buy SLSN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Sign upAnalyst Views on SLSN
About SLSN
Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nanophase Technologies GAAP EPS of $0.04, revenue of $20.4M
Financial Performance: Nanophase Technologies reported a Q2 GAAP EPS of $0.04 and revenue of $20.4 million.
Market Developments: Solesence, Inc. is experiencing growth but faces stock price challenges, while other materials stocks are joining the Russell Microcap Index.
Solésence Expands Debt Facilities to Fuel Growth Initiatives
Loan Agreement Amendments: Solésence, Inc. has amended its loan agreements to increase borrowing capacity from $14.2 million to $23.0 million and extended the maturity date to April 30, 2027, providing financial flexibility for strategic objectives.
Company Overview: Solésence is a leader in health care solutions within beauty and life sciences, focusing on innovative mineral-based sun protection and empowering brand partners through enhanced product offerings.